Author Archives: admin

be an advocate fight crc

Seniors and the Screening Loophole

Seniors and the Screening Loophole

“But doctor, I thought screening for colorectal cancer was covered by Medicare!?” Our seniors are facing policy loophole that lands them with an unexpected bill. In a recent report, Colonoscopy Screening After the Affordable Care Act: Cost Barriers Persist for Medicare Beneficiaries on the colonoscopy copay issue by AARP, there continues to be a debate about what portion of a preventative service a patient should be responsible for. For our seniors, prior to the implementation of the Affordable Care Act (ACA), Medicare beneficiaries typically incurred some level of cost sharing for health care services they received. For example, they were responsible for Part B premiums, Part B Deductibles, and a 20 percent coinsurance

Thank You For Seven Great Years

Seven years. That’s how long I’ve been at the helm of Fight Colorectal Cancer as its president. My experience with cancer seven years ago was limited to my father’s very brief and devastating fight with lung cancer and myelodysplatic syndrome. But since then, I’ve testified before Congress and the Food and Drug Administration, traveled to Europe to meet with international cancer activists, rang the Opening Bell at the New York Stock Exchange and the Opening and Closing Bells at NASDAQ, railed against Dr. Oz, led Fight Colorectal Cancer through a rebranding, met some amazing advocates, and lost some dear friends, board members (one of whom was a tremendous mentor to

Fight Colorectal Cancer Offers Input on Virtual Colonoscopy to FDA

On Monday, Fight Colorectal Cancer’s director of patient information services, Kim Ryan, attended a discussion panel hosted by the Food & Drug Administration (FDA) focusing on Gastroenterology/Urology and Radiological Devices on Computed Tomography Colonography (CTC). The 26-member panel discussed the risks and benefits of computed tomography colonography (virtual colonoscopy) for patients not experiencing any signs or symptoms of colorectal cancer. The panel discussed questions such as: The potential benefits of CTC for screening  Safety issues related to the use of CTC The role of CTC as one option for screening patients displaying no symptoms of CRC As an organization, we voiced our opinions through formal comments sent before the panel discussion, and submitted verbal comments at

Oregon Advocates Meet at White House

Yesterday two of our long-time colorectal cancer advocates, LaRisha and Michell Baker, along with president Carlea Bauman and policy expert Camille Bonta, met with Tricia Schmitt at the White House. Ms. Schmitt met with our advocates to discuss funding for colorectal cancer programs at the Centers for Disease Control (CDC.)   Our team, joined by two gastroenterologists, met at the White House to talk about the importance of maintaining the funding for lifesaving programs like the CDC’s Colorectal Cancer Control Program (CRCCP)  currently in 26 states and four tribes. As co-chairs of the cancer control committee in Oregon, the Baker sisters gave first-hand stories and statistics about the importance funding of CDC in Oregon. The

You got Science in our RATS Boot Camp . . .

What happens when you combine colorectal cancer survivors and a scientist? You get a force to be reckoned with! The RATS program was started by Fight Colorectal Cancer founder Nancy Roach and our late Director of Research Kate Murphy over 6 years ago, as a way to work hand in hand with the scientific community across the country. In 2012, Dan Dixon joined our advocacy efforts and has embraced the idea that survivors can be trained to participate in and and be a part of the research discussions. Bringing his own institution on board the University of Kansas Cancer Center higlighted our partnership and the good work we are doing

You’ve Got Mail – Get Screened for Colon Cancer!

Earlier this week, the Journal of the American Medicine Association (JAMA) Internal Medicine reported that according to a Texas study, mailings encouraging colorectal cancer (CRC) screening proved to be effective among underserved patients. Dr. Samir Gupta of the University of Texas Southwestern Medical Center served as the investigator. Polymedco, producer of the FIT test collaborated on the study. The study targeted uninsured patients ages 54-64 years old who were not up-to-date with CRC screening and enrolled in a program for those with limited or no access to health care. Two separate mailings, as well as a follow-up reminder phone call, offered patients one of the following: #1 -  A FIT test (fecal immunochemical